Atlas Trials

Single-dose Study to Investigate the Plasma PK of KW-6356 and Its Major Metabolite

Clinical trial NCT04190654 · COMPLETED

Trial details

NCT number
NCT04190654
Sponsor
Kyowa Kirin, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2019-11-26
Primary completion
2020-03-20
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.